Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Oct 13 - Oct 18
is a novel hydroxamic acid-type histone deacetylase (HDAC) inhibitor with antineoplastic activity
Formula: C15H22O3
25-trihydroxy-15-[(1R)-1-hydroxyethyl]-2
InChiKey: CPEUVMUXAHMANV-UHFFFAOYSA-N
Formula: C23H24N4O6
MRS 2578 Size:Solid 10 mg is a novel hydroxamic acid-typeMRS 2578 is a selective antagonist of P2Y6 nucleotide receptors (IC50 values are 37 and 98 nM at human and rat P2Y6 receptors respectively). Activation of P2Y6 receptor amplifies mucosal adenosine triphosphate release underlying bladder overactivity in patients with benign prostatic hyperplasia. Therefore, selective P2Y6 receptor blockade as a novel therapeutic strategy is potentially useful to control persistent storage symptoms in obstructed
US$ 599.00
US$ 188.00
US$ 168.00
US$ 190.00
US$ 121.25
US$ 262.00
US$ 160.04
US$ 1156.00
US$ 19.00
US$ 525.00